I-SCREEN: Improving Strategies for Cancer Reduction through Early-detection and Engagement





CRSN Graphic

The Vanguard Study

This study aims to explore Multi-Cancer Detection (MDC) tests, which are blood tests designed to identify multiple types of cancer. There is still much to learn about this emerging technology, including its accuracy and the potential benefits for early cancer detection.

MCD tests have great potential to improve cancer screening and outcomes, but fundamental  research through the Vanguard Study is essential to confirm their benefits and ensure they are implemented safely in various healthcare settings.



Contact:

CMS Login